Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Cazin · SciRah

Researcher profile · Semantic Scholar

B. Cazin

Share profile

B. Cazin — researcher profile on SciRah

h-index: 30
Works: 80
Citations: 5,696

Most-cited papers

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.
M. Hallek, K. Fischer, G. Fingerle-Rowson, A. Fink +28 more
2010The Lancet1,897 citations
Semantic Scholar
Chlorambucil in Indolent Chronic Lymphocytic Leukemia
G. Dighiero, K. Maloum, B. Desablens, B. Cazin +8 more
1998441 citations Open access
Semantic Scholar
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
M. Leporrier, S. Chevret, B. Cazin, N. Boudjerra +12 more
2001Blood425 citations
Semantic Scholar
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.
C. Dearden, E. Matutes, B. Cazin, G. Tjønnfjord +11 more
2001Blood329 citations Open access
Semantic Scholar
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
H. Walter, S. Rule, M. Dyer, Lionel Karlin +19 more
2016Blood271 citations Open access
Semantic Scholar
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed.
M. Keating, B. Cazin, S. Coutre, R. Birhiray +9 more
2002Journal of Clinical Oncology199 citations
Semantic Scholar
Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
G. Dighiero, K. Maloum, B. Desablens, B. Cazin +8 more
1998New England Journal of Medicine173 citations
Semantic Scholar
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations
B. Cazin, N. Gorin, J. Laporte, B. Gallet +4 more
1986Cancer155 citations
Semantic Scholar
Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response Rates and Progression-Free Survival (PFS) of Previously Untreated Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)
M. Hallek, G. Fingerle-Rowson, A. Fink, R. Busch +25 more
2008146 citations
Semantic Scholar
Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.
O. Tournilhac, B. Cazin, S. Leprêtre, M. Diviné +13 more
2004Blood118 citations
Semantic Scholar
Chronic lymphocytic leukaemia cells are efficiently killed by an anti‐CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16
C. de Romeuf, C. Dutertre, M. Le Garff-Tavernier, N. Fournier +12 more
2008British Journal of Haematology115 citations
Semantic Scholar
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
V. Leblond, Vincent Lévy, F. Maloisel, B. Cazin +12 more
2001Blood103 citations Open access
Semantic Scholar
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
S. Leprêtre, T. Aurran, B. Mahé, B. Cazin +15 more
2012Blood93 citations
Semantic Scholar
Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)
C. Preudhomme, N. Henic, B. Cazin, J. Laï +8 more
1997Leukemia92 citations Open access
Semantic Scholar
Multicenter Outbreak of Infections by Saprochaete clavata, an Unrecognized Opportunistic Fungal Pathogen
S. Vaux, A. Criscuolo, M. Desnos-Ollivier, L. Diancourt +124 more
2014mBio87 citations Open access
Semantic Scholar
Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.
A. Madani, V. Choukroun, J. Soulier, V. Cacheux +9 more
1996Blood74 citations
Semantic Scholar
Stem cell transplantation after alemtuzumab in T‐cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
Biju Krishnan, M. Else, G. Tjønnfjord, B. Cazin +7 more
2010British Journal of Haematology71 citations
Semantic Scholar
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
C. Herling, F. Cymbalista, Carolin Groß-Ophoff-Müller, J. Bahlo +23 more
2020Leukemia70 citations Open access
Semantic Scholar
Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia
Julien Rossignol, A. Michallet, L. Obéric, M. Picard +6 more
2011Leukemia67 citations
Semantic Scholar
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II study
E. Van Den Neste, B. Cazin, A. Janssens, E. González-Barca +7 more
2012Cancer Chemotherapy and Pharmacology54 citations Open access
Semantic Scholar
Transplantation in Waldenstrom's macroglobulinemia--the French experience.
O. Tournilhac, V. Leblond, R. Tabrizi, R. Gressin +11 more
2003Seminars in Oncology53 citations
Semantic Scholar
Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia
E. Bouvet, C. Borel, L. Obéric, Gisèle Compaci +4 more
2013Haematologica48 citations Open access
Semantic Scholar
Rituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia
A. Michallet, J. Rossignol, B. Cazin, L. Ysebaert
2011Leukemia and Lymphoma48 citations
Semantic Scholar
Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis.
Vincent Lévy, Raphaël Porcher, Fabrice Delabarre, M. Leporrier +2 more
2001Journal of Clinical Epidemiology46 citations
Semantic Scholar
Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk Binet Stage A Chronic Lymphocytic Leukemia – First Results Of a Randomized German-French Cooperative Phase III Trial
C. Schweighofer, F. Cymbalista, C. Müller, R. Busch +16 more
201345 citations
Semantic Scholar
Bendamustine is effective in T‐Cell prolymphocytic leukaemia
C. Herbaux, P. Genet, K. Bouabdallah, J. Pignon +9 more
2015British Journal of Haematology44 citations Open access
Semantic Scholar
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients
A. Delannoy, C. Sebban, P. Cony-Makhoul, B. Cazin +10 more
1997Leukemia43 citations
Semantic Scholar
Treatment of Acute Lymphoblastic Leukemia in the Elderly: An Evaluation of Interferon Alpha Given as a Single Agent After Complete Remission
A. Delannoy, B. Cazin, X. Thomas, R. Bouabdallah +12 more
2002Leukemia and Lymphoma31 citations
Semantic Scholar
Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW
S. Stilgenbauer, F. Cymbalista, V. Leblond, A. Delmer +18 more
201130 citations
Semantic Scholar
Subcutaneous Alemtuzumab Combined with Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT In CLL with 17p- or Refractory to Fludarabine – Interim Analysis of the CLL2O Trial of the GCLLSG and FCGCLL/MW
S. Stilgenbauer, F. Cymbalista, V. Leblond, A. Delmer +17 more
201030 citations
Semantic Scholar
IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide
K. Maloum, C. Settegrana, E. Chapiro, B. Cazin +10 more
2009Annals of Hematology30 citations Open access
Semantic Scholar
Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL).
C. Magnac, L. Sutton, B. Cazin, C. Laurent +4 more
1999Hematology and Cell Therapy30 citations
Semantic Scholar
Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations
A. Madani, V. Choukroun, J. Soulier, V. Cacheux +9 more
199624 citations
Semantic Scholar
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: The French intergroup experience
L. Fornecker, T. Aurran-Schleinitz, A. Michallet, B. Cazin +11 more
2015American journal of hematology/oncology23 citations Open access
Semantic Scholar
Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia
C. Dartigeas, E. Van Den Neste, C. Berthou, H. Maisonneuve +21 more
2016Leukemia and Lymphoma22 citations
Semantic Scholar
High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia
B. Cazin, M. Diviné, S. Leprêtre, P. Travade +15 more
2008British Journal of Haematology21 citations Open access
Semantic Scholar
Evaluating treatment strategies in advanced Waldenström macroglobulinemia: use of quality-adjusted survival analysis
V. Lévy, Raphaël Porcher, V. Leblond, J. Fermand +6 more
2001Leukemia18 citations Open access
Semantic Scholar
Successful autologous bone marrow transplantation in second remission of malignant histiocytosis.
B. Cazin, N. Gorin, J. Jouet, J. Laporte +5 more
1990Bone Marrow Transplantation14 citations
Semantic Scholar
Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in “ultra High-risk” CLL: Final Results from the CLL2O Phase II Study
S. Stilgenbauer, F. Cymbalista, V. Leblond, A. Delmer +18 more
201413 citations
Semantic Scholar
First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis.
A. Michallet, B. Cazin, E. Bouvet, L. Obéric +6 more
2013Journal of Geriatric Oncology12 citations
Semantic Scholar
Prognostic factors in Waldenstrom's macroglobulinemia: description of the complications during the evolution-preliminary results on 101 patients.
L. Stalnikiewicz, I. Carrotte-Lefebvre, L. Detourmignies, C. Rose +3 more
2003Seminars in Oncology11 citations
Semantic Scholar
Multicentre Phase I Study with an 8-Dose Regimen of Single Agent Anti-CD20 Monoclonal Antibody LFB-R603 in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)
B. Cazin, S. Leprêtre, B. Coiffier, T. Aurran +6 more
201110 citations
Semantic Scholar
BRIEF COMMUNICATION Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL)
C. Preudhomme, N. Henic, B. Cazin, M. Berthéas +7 more
19978 citations
Semantic Scholar
First‐line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study
G. Meunier, L. Ysebaert, P. Nguyen-Thi, S. Leprêtre +16 more
2017Hematological Oncology7 citations
Semantic Scholar
A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia.
K. Maloum, F. Charlotte, M. Diviné, B. Cazin +2 more
2006Haematologica7 citations
Semantic Scholar
Cost effectiveness of oral fludarabine in chronic lymphocytic leukaemia: the French case
B. Dervaux, X. Lenne, D. Theis, M. d'Alché-Gautier +4 more
20076 citations
Semantic Scholar
Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia
P. Feugier, T. Aurran, B. Mahé, R. Letestu +17 more
2018Haematologica5 citations Open access
Semantic Scholar
Clinical Outcome of Stem Cell Transplantation(SCT) in Patients with T Cell Prolymphocytic Leukaemia(T-PLL) Previously Treated with Alemtuzumab: A Multicentre Experience.
Biju Krishnan, J. Swansbury, B. Cazin, R. Ireland +7 more
20055 citations
Semantic Scholar
Bendamustine, Ofatumumab and High-Dose Methylprednisolone (BOMP) in Relapsed/Refractory CLL: Results of a Planned Interim Analysis of the French CLL Intergroup ICLL01 Phase II Trial
S. de Guibert, M. Dilhuydy, L. Ysebaert, L. Sanhes +19 more
20144 citations
Semantic Scholar
[Chronic lymphocytic leukaemia presenting with specific cutaneous infiltrates in the absence of lymphocytosis: Two cases].
M. Vonarx, O. Carpentier, B. Cazin, B. Bouchindhomme +1 more
2012Annales de dermatologie et de vénéréologie4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Leblond×17
Invite
V. Leblond — researcher profile on SciRah
S. Leprêtre×13
Invite
S. Leprêtre — researcher profile on SciRah
O. Tournilhac×11
Invite
O. Tournilhac — researcher profile on SciRah
A. Delmer×11
Invite
A. Delmer — researcher profile on SciRah

×10

Invite

P. Feugier — researcher profile on SciRah

F. Cymbalista×10

Invite

F. Cymbalista — researcher profile on SciRah

Invite

B. Dreyfus — researcher profile on SciRah

Invite

K. Maloum — researcher profile on SciRah

Invite

L. Ysebaert — researcher profile on SciRah

Invite

M. Hallek — researcher profile on SciRah

Invite

H. Döhner — researcher profile on SciRah

S. Stilgenbauer×7

Invite

S. Stilgenbauer — researcher profile on SciRah